FIGURES AND TABLES
FROM:
Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTII
S C Benoit, R J Sheldon, E L Air, P Messerschmidt, K A Wilmer, K M B Hodge, M B Jones, D M M Eckstein, C C McOsker, S C Woods and R J Seeley
BACK TO ARTICLEFigure 1.
Mean preference ratio (saccharin intake/total fluid intake) after i.p. administration of MTII. * P<0.05.
Full figure and legend (41K)Figure 2.
Mean preference ratio (saccharin intake/total fluid intake) after i.v. administration of MTII. * P<0.05.
Full figure and legend (42K)Figure 3.
Mean preference ratio (saccharin intake/total fluid intake) after s.c. administration of MTII. * P<0.05.
Full figure and legend (37K)Figure 4.
Mean cumulative food and fluid intakes during phase II of Experiment 2a: (a) 7-day food intake and (b) 7-day fluid intake. * P<0.05.
Full figure and legend (64K)Figure 5.
Mean preference ratio during the 24-h test after Experiment 2a. * P<0.05.
Full figure and legend (29K)Figure 6.
Mean preference ratio during the 24-h test after Experiment 2b. * P<0.05.
Full figure and legend (30K)Figure 7.
Mean preference ratio during the 24-h test of Experiment 3. Left-hand bars represent data for ob/ob mice and right-hand bars represent data for wild-type controls. * P<0.05.
Full figure and legend (40K)